Search - tctmd.com

Displaying 401 - 420 of 1494

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks

News Daily News

Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks

November 30, 2022

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

News Daily News

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Michael O'Riordan

November 24, 2022

Age-Related Macular Degeneration Linked to Severe Vascular Disease

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

November 18, 2022

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

November 16, 2022

AHA Statement Stresses Importance of Telehealth in CVD Care

News Daily News

AHA Statement Stresses Importance of Telehealth in CVD Care

Yael L. Maxwell

November 16, 2022

Mindfulness Could Combat Uncontrolled Hypertension: MB-BP

News Conference News AHA 2022

Mindfulness Could Combat Uncontrolled Hypertension: MB-BP

Yael L. Maxwell

November 14, 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

November 09, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

News Conference News AHA 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

November 08, 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

November 05, 2022

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

News Daily News

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

November 01, 2022

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

News Daily News

Low-Carb Diet Promising for Lowering Blood Sugar in Prediabetes

October 28, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

October 11, 2022

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

News Daily News

Aortic Dissection Risk Rises With Thoracic Aneurysm Size: Large Network Study

Yael L. Maxwell

October 10, 2022

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.